PROGEN closed today lower at kr0.1, a decrease of -30.1003% from yesterday's close, completing a monthly decrease of -86.1772% or -kr0.65. Over the past 12 months, PROGEN stock lost -66.3987%.
PROGEN is not paying dividends to its shareholders.
The last earnings report, released on May 31, 2024, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Prostatype Genomics AB has completed 1 stock splits, with the recent split occurring on Oct 31, 2024.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XSTO (SEK).